Background: Histone demethylases (HDMs) have a prominent role in epigenetic regulation and are emerging as potential therapeutic cancer targets. The search for small molecules able to inhibit HDMs in vivo is very active but at the present few compounds were found to be specific for defined classes of these enzymes. Methodology/Principal Findings: In order to discover inhibitors specific for H3K4 histone demethylation we set up a screening system which tests the effects of candidate small molecule inhibitors on a S. cerevisiae strain which requires Jhd2 demethylase activity to efficiently grow in the presence of rapamycin. In order to validate the system we screened a library of 45 structurally different compounds designed as competitive inhibitors of alpha -ketoglutarate (alpha-KG) cofactor of the enzyme, and found that one of them inhibited Jhd2 activity in vitro and in vivo. The same compound effectively inhibits human Jumonji AT-Rich Interactive Domain (JARID) 1B and 1D in vitro and increases H3K4 tri-methylation in HeLa cell nuclear extracts (NEs). When added in vivo to HeLa cells, the compound leads to an increase of tri-methyl-H3K4 (H3K4me3) but does not affect H3K9 tri-methylation. We describe the cytostatic and toxic effects of the compound on HeLa cells at concentrations compatible with its inhibitory activity. Conclusions/Significance: Our screening system is proved to be very useful in testing putative H3K4-specific HDM inhibitors for the capacity of acting in vivo without significantly altering the activity of other important 2-oxoglutarate oxygenases.

An High-Throughput In Vivo Screening System to Select H3K4-Specific Histone Demethylase Inhibitors / Cecilia, Mannironi; Proietto, Marco; Bufalieri, Francesca; Enrico, Cundari; Alagia, ANGELA ALESSANDRA; Danovska, Svetlana; Rinaldi, Teresa; Famiglini, Valeria; Coluccia, Antonio; LA REGINA, Giuseppe; Silvestri, Romano; Negri, Rodolfo. - In: PLOS ONE. - ISSN 1932-6203. - 9:1(2014), pp. e86002-e86002. [10.1371/journal.pone.0086002]

An High-Throughput In Vivo Screening System to Select H3K4-Specific Histone Demethylase Inhibitors

PROIETTO, MARCO;BUFALIERI, FRANCESCA;ALAGIA, ANGELA ALESSANDRA;DANOVSKA, SVETLANA;RINALDI, Teresa;FAMIGLINI, VALERIA;COLUCCIA, Antonio;LA REGINA, GIUSEPPE;SILVESTRI, Romano;NEGRI, RODOLFO
2014

Abstract

Background: Histone demethylases (HDMs) have a prominent role in epigenetic regulation and are emerging as potential therapeutic cancer targets. The search for small molecules able to inhibit HDMs in vivo is very active but at the present few compounds were found to be specific for defined classes of these enzymes. Methodology/Principal Findings: In order to discover inhibitors specific for H3K4 histone demethylation we set up a screening system which tests the effects of candidate small molecule inhibitors on a S. cerevisiae strain which requires Jhd2 demethylase activity to efficiently grow in the presence of rapamycin. In order to validate the system we screened a library of 45 structurally different compounds designed as competitive inhibitors of alpha -ketoglutarate (alpha-KG) cofactor of the enzyme, and found that one of them inhibited Jhd2 activity in vitro and in vivo. The same compound effectively inhibits human Jumonji AT-Rich Interactive Domain (JARID) 1B and 1D in vitro and increases H3K4 tri-methylation in HeLa cell nuclear extracts (NEs). When added in vivo to HeLa cells, the compound leads to an increase of tri-methyl-H3K4 (H3K4me3) but does not affect H3K9 tri-methylation. We describe the cytostatic and toxic effects of the compound on HeLa cells at concentrations compatible with its inhibitory activity. Conclusions/Significance: Our screening system is proved to be very useful in testing putative H3K4-specific HDM inhibitors for the capacity of acting in vivo without significantly altering the activity of other important 2-oxoglutarate oxygenases.
2014
histone methylation; jarid; epigenetics; anticancer drug; high throughput screening (hts); transcription regulation; histone demethylase inhibitors
01 Pubblicazione su rivista::01a Articolo in rivista
An High-Throughput In Vivo Screening System to Select H3K4-Specific Histone Demethylase Inhibitors / Cecilia, Mannironi; Proietto, Marco; Bufalieri, Francesca; Enrico, Cundari; Alagia, ANGELA ALESSANDRA; Danovska, Svetlana; Rinaldi, Teresa; Famiglini, Valeria; Coluccia, Antonio; LA REGINA, Giuseppe; Silvestri, Romano; Negri, Rodolfo. - In: PLOS ONE. - ISSN 1932-6203. - 9:1(2014), pp. e86002-e86002. [10.1371/journal.pone.0086002]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/538415
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 10
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 14
social impact